HCA Healthcare, Inc. (HCA)
NYSE: HCA · Real-Time Price · USD
351.65
+4.62 (1.33%)
Apr 3, 2025, 1:45 PM EDT - Market open
HCA Healthcare Stock Forecast
Stock Price Forecast
The 15 analysts with 12-month price forecasts for HCA Healthcare stock have an average target of 380.2, with a low estimate of 320 and a high estimate of 440. The average target predicts an increase of 8.12% from the current stock price of 351.65.
Analyst Consensus: Buy
* Price targets were last updated on Jan 27, 2025.
Analyst Ratings
The average analyst rating for HCA Healthcare stock from 16 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 3 | 3 | 4 | 4 | 4 |
| Buy | 7 | 6 | 6 | 7 | 7 | 7 |
| Hold | 6 | 5 | 5 | 4 | 4 | 4 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 15 | 15 | 16 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $405 → $384 | Buy | Maintains | $405 → $384 | +9.20% | Jan 27, 2025 |
| B of A Securities | B of A Securities | Strong Buy Maintains $380 → $370 | Strong Buy | Maintains | $380 → $370 | +5.22% | Jan 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $405 | Buy | Reiterates | $405 | +15.17% | Jan 27, 2025 |
| Barclays | Barclays | Buy Maintains $392 → $366 | Buy | Maintains | $392 → $366 | +4.08% | Jan 27, 2025 |
| Keybanc | Keybanc | Buy Maintains $420 → $370 | Buy | Maintains | $420 → $370 | +5.22% | Jan 7, 2025 |
Financial Forecast
Revenue This Year
75.41B
from 70.60B
Increased by 6.80%
Revenue Next Year
79.29B
from 75.41B
Increased by 5.15%
EPS This Year
25.13
from 22.00
Increased by 14.24%
EPS Next Year
28.35
from 25.13
Increased by 12.80%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 79.6B | 85.3B | 90.2B | ||
| Avg | 75.4B | 79.3B | 83.4B | ||
| Low | 72.3B | 75.5B | 78.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.8% | 13.1% | 13.7% | ||
| Avg | 6.8% | 5.1% | 5.2% | ||
| Low | 2.4% | 0.1% | -0.6% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 26.70 | 30.84 | 34.14 | ||
| Avg | 25.13 | 28.35 | 31.62 | ||
| Low | 22.94 | 26.47 | 29.70 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 21.4% | 22.7% | 20.4% | ||
| Avg | 14.2% | 12.8% | 11.5% | ||
| Low | 4.3% | 5.3% | 4.8% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.